Universal Biosensors, Inc. (UBI)

Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!

General Information
Company Name: Universal Biosensors, Inc.
Stock Code: UBI
Website: www.universalbiosensors.com
GICS Sub-Industry: Health Care Services
Market Cap ($M): 26
Equiv. Shares (M): 175

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
$ 0.150 $ 0.170 $ 0.170 $ 0.150 $ 0.150 26,945 0%

Company Overview

Business Description:
Universal Biosensors Inc. (UBI) is a specialist medical diagnostics company focusing on research, development, manufacture and commercialisation of in vitro diagnostic devices for consumer and professional point of care use. UBI has developed a blood glucose monitoring product that is being commercialised globally by LifeScan, Inc. a Johnson & Johnson company.

Strategy Analysis:
UBI's strategy involves: manufacturing blood glucose test strips for LifeScan; providing post market support services to LifeScan in connection with the blood glucose test; continuing to undertake contract research and development work on behalf of LifeScan and seeking to develop additional products in the field of diabetes and blood glucose monitoring for LifeScan; extending the electrochemical cell technology by developing new non-blood glucose tests and; entering into collaborative arrangements or strategic alliances with other life sciences companies or other industry participants to complete the development and commercialisation of UBI's non-blood glucose tests. Universal Biosensors reported net loss of $9.13m for the year ended 31 December 2012. Revenue from ordinary activities were $29.65m. Basic and Diluted EPS were (5.7) cents compared to (9) cents last year. The net operating cash outflow was $3.3m compared to an outflow of $7.16m in the pcp. No dividend was declared.

Financial Summary
Year to Dec NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2013  A -11.6 -6.7 -- 0.0 0.0 0.0 --
2012  A -9.1 -5.7 -- 0.0 0.0 0.0 --
2011  A -14.7 -9.2 -- 0.0 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2011 A 2012 F 2013 F 2011 A 2012 F 2013 F 2011 A 2012 F 2013 F
Capitol Health (CAJ) $270 M 0.7872 -- -- 37.2024 -- -- 1.44 -- --
Universal Biosensors (UBI) $26 M -- -- -- -- -- -- 0.00 -- --
Virtus Health (VRT) $577 M 1.2932 0.1858 0.1806 18.7630 15.8229 13.4026 3.60 3.94 4.65

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
UBI -- -- 0.89 -- 1.19
Market 0.91 15.2 1.18 1.87 1.52
Sector 0.66 18.6 2.35 1.65 1.98

Name Position Start Date
Mr Paul Wright Chief Executive Officer,Managing Director 01 March 2011
Mr Andrew Leslie Denver Executive Chairman 31 December 2002
Dr Colin McLean Adam Non-Executive Director 10 July 2002
Mr Denis Michael Hanley Non-Executive Director 21 September 2001
Mr Andrew Jane Non-Executive Director 15 August 2006
Mr Marshall Heinberg Non-Executive Director 11 January 2010
Mr Christopher Smith Non-Executive Director 27 August 2013

Name Position
Salesh Balak Chief Financial Officer
Cameron David Billingsley Company Secretary

Substantial Shareholders
Holding Name
18,675,792 (10.64%) National Nominees Limited
17,794,384 (10.13%) Talu Ventures Pty Ltd and its associates
17,451,074 (9.94%) The Principals Cornerstone Fund Pty Ltd
13,999,077 (7.97%) Aust Executor Trustees SA Ltd

Calendar of Events
Date Event
23 July 2015 Report (Interim)
13 April 2015 Report (Annual)
12 March 2015 Report (Annual)
12 February 2015 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.


Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Debt Relief

An educational booklet to help you take control of your debts and look to get back on track.

More details...


Australian Share Market - Close Up

CMC Markets 11/11/2014 | The Australian share market is in a decision zone - and trading from here may set the direction for the rest of the year.

Prices slashed - everything must go!

Nick Swales, Regional Director, Newcastle Office, Rathbones 27/10/2014 | “If you want to have a better performance than the crowd, you must do things differently from the crowd.” Sir John Templeton.

Aussie share market bulls now have company

Ric Spooner (Chief Market Analyst, CMC Markets) 20/10/2014 | Today, Australian investors will not have to go it alone buying stocks as they did for much of last week. Bargain hunters this morning will be supported by the morale boosting encouragement of a 3% turnaround in the German Dax and a 264 point rally in the Dow Jones.

The Importance of Ignoring the Noise of the Market

Carl Richards, director of investor education at the BAM Alliance 17/10/2014 | “As odd as it may sound, the sooner you start treating your investments like you treat life, the happier you’ll be with the outcome.”

You only dance twice

William H. Gross, Janus Capital Group 16/10/2014 | “Financial markets are artificially priced. In the bond market, there is nothing normal about a three year German Bund yielding “minus” 10 basis points.”

The Big Picture - Australia 200 Index

CMC Markets 8/10/2014 | Share market indices around the globe are breaking down. While analysts cast around for reasons, it’s clear that a time factor is in play. Simply put, many investors “feel” a correction is overdue. How low could it go?


Sponsored Links